NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/28/2024
Back to search
Official data from USPTO
AAVALABS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
12/28/2024
Trademark type
Combined
Nice classes
5
Filing date
01/14/2021
Registration date
02/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/08/2022
Last transaction
02/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
FI
Examiner
SANTIAGO, ALEXIS
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a rectangle with a straight left, top, and right side with the bottom side forming a silhouette of four mountain peaks. Below is the wording AAVALABS in stylized, block text.
Holders and representatives
Holders
Nordic By Nature Oy
Representatives
Geza C. Ziegler Jr. ZIEGLER IP LAW GROUP LLC.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical purposes; dietary supplements and dietetic preparations adapted for medical purposes; pharmaceuticalspsychotropics and natural remedy preparations for the treatment of gastro-intestinal conditionshormonal and chemical imbalancessleep disorders; vitamin a preparations; alginate dietary supplements; food supplements consisting of amino acids; food supplementsantioxidants; anti-oxidant food supplements; asthmatic tea; meal replacement powders adapted for medical use; vitamin b preparations; vitamin c preparations; vitamin d preparations; artificial sweeteners adapted for diabetics; dietary and nutritional supplements; dietary supplements consisting of vitamins; nutraceuticals for use as a dietary supplement; dietetic confectionery adapted for medical purposes; dietary supplements for controlling cholesterol; dietetic foods adapted for medical use; dietary supplemental drinks; mineral food supplements; enzyme dietary supplements; glucose for use as an additive to foods for medical purposes; powdered fruit-flavored dietary supplement drink mix; glucose dietary supplements; food supplements consisting of trace elements; cod liver oil; dietetic beverages adapted for medicinal purposes; edible fish oil for medical purposes; casein dietary supplements; mineral nutritional supplements; mineral dietary supplements for humans; mineral food supplements; mineral water salts for medical purposes; dietary fiber to aid digestion; medicinal tea; diet capsules; slimming pills; baby food; nutritional supplements; dietary supplements for humans; lecithin dietary supplements; lipotropic factor preparations; health food supplements for persons with special dietary requirements; lysine preparations; royal jelly dietary supplements; multi-vitamin preparations; multi-vitamin preparations; liquid vitamin supplements; liquid herbal supplements; nutritional supplements consisting primarily of calcium; nutritional supplements consisting primarily of magnesium; nutritional supplements consisting primarily of iron; nutritional supplements consisting primarily of zinc; health food supplements made principally of minerals; health food supplements made principally of vitamins; freeze-dried food adapted for medical purposes; flaxseed dietary supplements; ground flaxseed fiber for use as a dietary supplement; flaxseed oil dietary supplements; probiotic supplements; protein dietary supplements; dietary supplements consisting primarily of iron; dietary supplements consisting primarily of magnesium; dietary supplements consisting primarily of calcium; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; powdered nutritional supplement drink mix; appetite suppressants; appetite stimulant preparations; appetite suppressants; dietary supplements for humans not for medical purposes; nutritional supplements consisting of fungal extracts; bee pollen for use as a dietary food supplement; pollen dietary supplements; zinc supplement lozenges; soy isoflavone dietary supplements; soy protein dietary supplements; starch for pharmaceutical purposes; colostrum supplements; cod-liver oil capsules; cod-liver oil drops; albumin dietary supplements; wheat germ dietary supplements; wheat for use as dietary supplements; by-products of the processing of cereals for dietetic or medical purposes; vitamin and mineral supplements; dietary supplemental drinks in the nature of vitamin and mineral beverages; gummy vitamins; vitamin supplements; vitamin supplements for use in renal dialysis; effervescent vitamin tablets; vitamins and vitamin preparations; vitamin tablets; vitamin drops; vitamin preparations; vitamin preparations in the nature of food supplements; mixed vitamin preparations; herbal dietary supplements for persons with special dietary requirements; herbal dietary supplements for persons with special dietary requirements
Publications
History of USPTO decisions and trademark events.
28 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/08/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/23/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/02/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/09/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/18/2022
FIMP
FINAL DISPOSITION PROCESSED
07/18/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/08/2022
GPNX
NOTIFICATION PROCESSED BY IB
12/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/23/2021
PUBO
PUBLISHED FOR OPPOSITION
11/23/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/17/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/17/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/21/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/04/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/04/2021
RFNT
REFUSAL PROCESSED BY IB
09/20/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/26/2021
RFRR
REFUSAL PROCESSED BY MPU
08/26/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/13/2021
CNRT
NON-FINAL ACTION WRITTEN
08/12/2021
MAFR
APPLICATION FILING RECEIPT MAILED
08/07/2021
DOCK
ASSIGNED TO EXAMINER
08/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/03/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/29/2021
Continuous trademark protection
Get notified about every new filing that threatens AAVALABS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.